Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs in the Management of Neuroendocrine Tumors and Acromegaly: A Systematic Literature Review. [PDF]
Cella D +6 more
europepmc +1 more source
Heterodimerization, G-Protein-Coupled Receptors, somatostatin receptor, internalization, oligomerization, dimerization, homodimerization, GPCR, desensitization, immunoprecipitationMagdeburg, Univ., Fak.
Laugsch, Magdalena
core
Somatostatin analogs in the treatment of gastrointestinal angiodysplasia bleeding: a systematic review. [PDF]
Correa TL +8 more
europepmc +1 more source
Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study. [PDF]
Kuhn E +12 more
europepmc +1 more source
From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms. [PDF]
Melhorn P +5 more
europepmc +1 more source
Insights into structure-activity relationships of somatostatin analogs containing mesitylalanine
The non-natural amino acid mesitylalanine (2,4,6-trimethyl-L-phenylalanine; Msa) has an electron-richer and a more conformationally restricted side-chain than that of its natural phenylalanine counterpart.
Martín-Gago, Pablo +12 more
core
Long-acting somatostatin analogs and well differentiated neuroendocrine tumors: a 20-year-old story. [PDF]
Faggiano A.
europepmc +1 more source
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study. [PDF]
Brighi N +16 more
europepmc +1 more source
Pathological complete response of initially unresectable multiple liver metastases achieved using combined peptide receptor radionuclide therapy and somatostatin analogs following pancreatic neuroendocrine tumor resection: a case report. [PDF]
Umino R +8 more
europepmc +1 more source

